Dynavax Technologies
DVAX
DVAX was delisted on the 9th of February, 2026.
123 hedge funds and large institutions have $332M invested in Dynavax Technologies in 2016 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 41 increasing their positions, 29 reducing their positions, and 24 closing their positions.
100% more call options, than puts
Call options by funds: $55.3M | Put options by funds: $27.6M
41% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 29
2% more funds holding
Funds holding: 121 → 123 (+2)
8% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 24
1.54% less ownership
Funds ownership: 83.8% → 82.26% (-1.5%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
29% less capital invested
Capital invested by funds: $470M → $332M (-$138M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair & Company
Chicago,
Illinois
|
+$19.6M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$18.7M |
| 3 |
BC
Broadfin Capital
New York
|
+$11.5M |
| 4 |
SM
Senvest Management
New York
|
+$6.3M |
| 5 |
Goldman Sachs
New York
|
+$5.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$35M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$19.1M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$9.26M |
| 4 |
AC
Amici Capital
New York
|
-$6.77M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
-$5.54M |
DVAX Hedge Fund Activity: Q3 2016 in Review
123 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q3 2016, worth a combined $332M — down 29% from $470M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new DVAX positions and 24 closed out — a net gain of 2 holders — while 41 added to existing stakes and 29 trimmed.
The largest buyer was William Blair & Company, adding an estimated $19.6M. The largest seller was OrbiMed, exiting entirely with an estimated $35M sold.
- 123 institutional investors held Dynavax Technologies (DVAX) as of Q3 2016, up from 121 in Q2 2016.
- Funds reported $332M of Dynavax Technologies stock for Q3 2016, down 29% quarter-over-quarter.
- 26 funds opened new Dynavax Technologies positions in Q3 2016 and 24 closed out, a net change of +2 holders.
- The largest Dynavax Technologies buyer in Q3 2016 was William Blair & Company, an estimated $19.6M added.
- The largest Dynavax Technologies seller in Q3 2016 was OrbiMed, an estimated $35M sold.
Based on aggregated 13F filings for Q3 2016.